RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
35,233
35,233
218,505
10,393
4,589
Cost of Revenue
8,241
8,241
9,640
1,709
959
Gross Profit
26,992
26,992
208,865
8,684
3,630
Operating Expenses
Research Development
124,185
124,185
83,873
57,224
45,482
Selling General and Administrative
51,815
51,815
36,850
27,229
23,590
Total Operating Expenses
175,990
175,990
120,765
84,569
68,970
Operating Income or Loss
-148,998
-148,998
88,100
-75,885
-65,340
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
48,559
48,559
7,070
2,716
1,938
Income Before Tax
-97,488
-97,488
104,116
-73,169
-63,402
Income Tax Expense
-2,755
-2,755
4,179
-
-435
Income from Continuing Operations
-94,733
-94,733
99,937
-73,169
-62,967
Net Income
-94,733
-94,733
99,937
-73,169
-62,967
Net Income available to common shareholders
-94,733
-94,733
99,937
-73,169
-62,967
Basic EPS
-
-
2.99
-2.45
-2.38
Diluted EPS
-
-
2.73
-2.45
-2.38
Basic Average Shares
-
-
33,427
29,878
26,409
Diluted Average Shares
-
-
36,648
29,878
26,409
EBITDA
-
-141,846
92,082
-73,199
-62,858